Glioblastomas possess genetic alterations that target three core signaling pathways, including the RTK/RAS/PI3K axis, p53/MDM2/MDM4 axis, and RB/CDK4/INK4A axis (7). This evidence concerns the gene TP53 and glioblastoma.